These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23784625)

  • 1. Incidence of lymphoplasmacytic lymphoma/Waldenström's macroglobulinaemia in Japan and Taiwan population-based cancer registries, 1996-2003.
    Iwanaga M; Chiang CJ; Soda M; Lai MS; Yang YW; Miyazaki Y; Matsuo K; Matsuda T; Sobue T
    Int J Cancer; 2014 Jan; 134(1):174-80. PubMed ID: 23784625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Waldenström's macroglobulinemia: incidence patterns in the United States, 1988-1994.
    Groves FD; Travis LB; Devesa SS; Ries LA; Fraumeni JF
    Cancer; 1998 Mar; 82(6):1078-81. PubMed ID: 9506352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial Waldenstrom's macroglobulinemia and relation to immune defects, autoimmune diseases, and haematological malignancies--A population-based study from northern Sweden.
    Brandefors L; Kimby E; Lundqvist K; Melin B; Lindh J
    Acta Oncol; 2016; 55(1):91-8. PubMed ID: 26559865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Waldenström's macroglobulinemia.
    Herrinton LJ; Weiss NS
    Blood; 1993 Nov; 82(10):3148-50. PubMed ID: 8219203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence and survival of Waldenström's Macroglobulinaemia in South East England.
    Phekoo KJ; Jack RH; Davies E; Møller H; Schey SA;
    Leuk Res; 2008 Jan; 32(1):55-9. PubMed ID: 17416416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic algorithm of Waldenström's macroglobulinemia or lymphoplasmacytic lymphoma in Japan].
    Sekiguchi N
    Rinsho Ketsueki; 2021; 62(8):1139-1148. PubMed ID: 34497201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristic and outcome of lymphoplasmacytic lymphoma of non-Waldenstrom macroglobulinemia type: A Swedish lymphoma registry study.
    Brandefors L; Sander B; Lundqvist K; Kimby E
    Br J Haematol; 2022 Mar; 196(6):1362-1368. PubMed ID: 34959252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.
    Vitolo U; Ferreri AJ; Montoto S
    Crit Rev Oncol Hematol; 2008 Aug; 67(2):172-85. PubMed ID: 18499469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associated malignancies in patients with Waldenström's macroglobulinemia and their kin.
    Hanzis C; Ojha RP; Hunter Z; Manning R; Lewicki M; Brodsky P; Ioakimidis L; Tripsas C; Patterson CJ; Sheehy P; Treon SP
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):88-92. PubMed ID: 21454200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
    Vajdic CM; Landgren O; McMaster ML; Slager SL; Brooks-Wilson A; Smith A; Staines A; Dogan A; Ansell SM; Sampson JN; Morton LM; Linet MS
    J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):87-97. PubMed ID: 25174029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed response to fludarabine in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia.
    Del Giudice I; Matutes E; Osuji N; Parry-Jones N; Swansbury J; Catovsky D
    Haematologica; 2005 Feb; 90(2):268-70. PubMed ID: 15710588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-acquired infections associated with increased risk of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia.
    McShane CM; Murray LJ; Engels EA; Anderson LA
    Br J Haematol; 2014 Mar; 164(5):653-8. PubMed ID: 24528127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
    Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
    N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiology of Waldenström macroglobulinemia.
    McMaster ML
    Semin Hematol; 2023 Mar; 60(2):65-72. PubMed ID: 37099032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated risk of venous but not arterial thrombosis in Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
    Hultcrantz M; Pfeiffer RM; Björkholm M; Goldin LR; Turesson I; Schulman S; Landgren O; Kristinsson SY
    J Thromb Haemost; 2014 Nov; 12(11):1816-21. PubMed ID: 25196979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of secondary malignancies among patients with Waldenström macroglobulinemia: An analysis of the SEER database.
    Castillo JJ; Olszewski AJ; Hunter ZR; Kanan S; Meid K; Treon SP
    Cancer; 2015 Jul; 121(13):2230-6. PubMed ID: 25757851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A matched case-control study comparing features, treatment and outcomes between patients with non-IgM lymphoplasmacytic lymphoma and Waldenström macroglobulinemia.
    Castillo JJ; Itchaki G; Gustine JN; Meid K; Flynn CA; Demos MG; Guerrera ML; Jimenez C; Kofides A; Liu X; Munshi M; Tsakmaklis N; Patterson CJ; Xu L; Yang G; Hunter ZR; Treon SP
    Leuk Lymphoma; 2020 Jun; 61(6):1388-1394. PubMed ID: 31992103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.
    Kristinsson SY; Björkholm M; Goldin LR; McMaster ML; Turesson I; Landgren O
    Blood; 2008 Oct; 112(8):3052-6. PubMed ID: 18703425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of diffuse large B-cell lymphoma in a patient with Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma: clonal identity between two B-cell neoplasms.
    Shiseki M; Masuda A; Watanabe N; Fujii M; Kimura T; Yoshinaga K; Mori N; Teramura M; Motoji T
    Hematol Rep; 2011 Aug; 3(2):e10. PubMed ID: 22184531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cause-specific mortality in individuals with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia, 2000-2016.
    Dalal NH; Dores GM; Curtis RE; Linet MS; Morton LM
    Br J Haematol; 2020 Jun; 189(6):1107-1118. PubMed ID: 32090327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.